iNtODEWORLD | Our research is committed to finding effective treatment for life-threatening infectious diseases.
15234
home,page,page-id-15234,page-template,page-template-full_width,page-template-full_width-php,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

iNtODEWORLD

A Game Changer in Antibacterial Drugs for Superbugs and Persister Cells

We are committed to finding effective treatment for life-threatening infectious diseases.

maintopban1

A Game Changer in Antibacterials Treatment for Gram-negative bacteria, Ultimate Target of N-Rephasin® Technology

maintopban2

Eco-friendly, no Side-effects, Unique mode of action. Bacteriophages and Antibiotic Resistance in Bacteria

maintopban3

Opening a New Era in Anti-Fugal Agents. A New Type of Antifungal Agent, iN-EYD34

maintopban4

New Generation of Heme-Iron (Porphyrin-Fe) Novel concept iron deficiency anemia therapeutic agent

iNtRON Biotechnology, Inc.

iNtRON Bio has been focusing on the R&D investment since its foundation and accelerates development speed after the IPO in KOSDAQ. We are aiming for the ‘global R&D company’ ; and promoting the value of the company focused on the BIO New Drug by developing various ‘First-in-Class’ bio-drugs and conducting clinical studies in phases.

INSIDE iNtRON

  •   iNtRON Biotechnology has been conducting evaluation tests on the recombinant phage endolysins AP50-31 and LysB4, to validate their bacteriolytic properties against Bacillus genus. As a result, AP50-31 and LysB4 displayed rapid bacteriolytic activity against broad spectrum of Bacillus genus including Bacillus anthracis strains, and......

  • Global Shrimp Production Status Shrimp is a globally beloved food. Since it contains high-quality protein, calcium, minerals and vitamin B complexes, global demands for shrimps have constantly increased. Shrimps are mainly produced in China and Southeast Asia (Thailand, Vietnam and Indonesia), Latin America and India; more than......

  • iNtRON’s R&D Center was invited to “3rd World Congress and Exhibition on Antibiotics and Antibiotics Resistance“ as a speaker, in recognition of its study on SAL200. The topic of the conference was ‘The future of antibiotics: key opportunities & emerging therapies’, and prominent researchers from......

See All
seh

PIPELINES

iNtRON Bio has been focusing on the R&D investment since its foundation and accelerate development speed after the IPD in KOSDAQ. We are aiming for the ‘global R&D company’ ; and promoting the value of the company focused on the BIO New Drug by developing various ‘First-in-Class’ bio-drugs and conducting clinical studies in phases.

iNtODEWORLD, Inc is the US subsidiary of iNtRON Biotechnology, Inc.